[Intra-hepatic biliary cystadenocarcinoma].

Gastroenterol Clin Biol

Service des Maladies du Foie et de l'Appareil Digestif, Hôpital de Bicêtre, Le Kremlin-Bicêtre.

Published: November 1999

Biliary cystadenocarcinoma is a rare tumor of the intrahepatic biliary tract, which frequently develops in a preexisting benign biliary cystadenoma. In the present case, diagnosis was difficult because of the lack of specificity of clinical, biological and radiological findings. The correct diagnosis was only achieved by histological examination of the resected lesion. Macroscopically, the right lobe of the liver showed evidence of a whitish, multilolobed, malignant mass of about 6 cm in diameter. Upon light microscopic analysis, cysts were found to be lined with papillary forms. In some areas, epithelial cells were clearly malignant contrasting with persistent non dysplasic areas, suggesting the presence of underlying cystadenomas. Eleven months after complete surgical resection, the patient is in good condition with no evidence of recurrence.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[intra-hepatic biliary
4
biliary cystadenocarcinoma]
4
cystadenocarcinoma] biliary
4
biliary cystadenocarcinoma
4
cystadenocarcinoma rare
4
rare tumor
4
tumor intrahepatic
4
intrahepatic biliary
4
biliary tract
4
tract frequently
4

Similar Publications

Unlabelled: Chronic Hepatitis B (CHB) remains a major public health problem, leading to various complications such as liver fibrosis, cirrhosis, and hepatocellular carcinoma. The existing diagnostic markers for Hepatitis B virus (HBV) are limited in distinguishing different CHB phases and intra-hepatic viral replication activity. In the past few years, several non-invasive potential blood markers that reflect viral intra-hepatic replicative state more accurately have been in progress and are gaining importance.

View Article and Find Full Text PDF

Background: Stone impaction is an obstacle to successful laparoscopic common bile duct exploration (LCBDE). This study aims to identify the incidence, operative difficulties and techniques used to disimpact and remove impacted stones during LCBDE.

Methods: Prospectively collected data from a large series of LCBDE.

View Article and Find Full Text PDF

Background: Current biliary dilatation (BD) classifications are complex and based on cases including secondary BD, leading to unclear distinctions. Notably, congenital and secondary BD differ in etiology, symptoms, and prognosis.

Objective: To propose a more concise and more suitable classification of congenital biliary dilatation (CBD), and exploring the feasibility and effectiveness of this classification in diagnosis and treatment.

View Article and Find Full Text PDF

Since the Asian Pacific Association for the Study of the Liver (APASL) published guidelines on non-cirrhotic portal fibrosis/idiopathic portal hypertension in 2007, there has been a surge in new information, especially with the introduction of the term porto-sinusoidal vascular disorder (PSVD). Non-cirrhotic intra-hepatic causes of portal hypertension include disorders with a clearly identifiable etiology, such as schistosomiasis, as well as disorders with an unclear etiology such as non-cirrhotic portal fibrosis (NCPF), also termed idiopathic portal hypertension (IPH). This entity is being increasingly recognized as being associated with systemic disease and drug therapy, especially cancer therapy.

View Article and Find Full Text PDF
Article Synopsis
  • * Epidemiological studies indicate higher incidence rates of BTC in South and Central Asia, particularly for intrahepatic cholangiocarcinoma (iCCA), compared to much lower rates in Europe and the U.S.
  • * The review also highlights the varying frequency of MDM2 gene amplifications in BTC subtypes, with gallbladder cancer showing the highest amplification rates, emphasizing the importance of standardized assessment in BTC research.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!